Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://kallumxqkr598049.mybjjblog.com/semaglutide-a-potential-solution-for-obesity-51141904